Glutathione, vitamin e and oxidative stress in coronary artery disease: Relevance of age and gender

European Journal of Clinical Investigation

Volumn 39, Issue 4, 2009, Pages 267-272

  Cavalca, V ^a,b   Veglia, F ^b   Squellerio, I ^b   Marenzi, G ^b   Minardi, F ^b   De Metrio, M ^b   Cighetti, G ^c   Boccotti, L ^a   Ravagnani, P ^b   Tremoli, E ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c LITA VIALBA   (Italy)

Author keywords

Age; Coronary artery disease; Gender; Glutathione; Oxidative stress; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; GAMMA TOCOPHEROL; GLUTATHIONE; HEMOGLOBIN; MALONALDEHYDE;

AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; CARDIAC PATIENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME BLOOD LEVEL; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; VITAMIN BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; ANTIOXIDANTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY DISEASE; DISEASE SUSCEPTIBILITY; FEMALE; GLUTATHIONE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; RISK FACTORS; SEX FACTORS; VITAMIN E;

EID: 62349138500     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02094.x     Document Type: Article

References (40)

1. Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L, Novembrino C et al. Oxidative stress and homocysteine in coronary artery disease. Clin Chem 2001 47 : 887 92.
2. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003 91 : 7A 11A.
3. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004 84 : 1381 478.
4. Kromhout D. Fatty acids, antioxidants, and coronary heart disease from an epidemiological perspective. Lipids 1999 34 (Suppl. S27 31.
5. Baydas G, Yilmaz O, Celik S, Yasar A, Gursu MF. Effects of certain micronutrients and melatonin on plasma lipid, lipid peroxidation, and homocysteine levels in rats. Arch Med Res 2002 33 : 515 9.
6. Shimizu H, Kiyohara Y, Kato I, Kitazono T, Tanizaki Y, Kubo M et al. Relationship between plasma glutathione levels and cardiovascular disease in a defined population: the Hisayama study. Stroke 2004 35 : 2072 7.
7. McKechnie R, Rubenfire M, Mosca L. Antioxidant nutrient supplementation and brachial reactivity in patients with coronary artery disease. J Lab Clin Med 2002 139 : 133 9.
8. Pryor WA. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 2000 28 : 141 64.
9. Burton GW. Vitamin E: molecular and biological function. Proc Nutr Soc 1994 53 : 251 62.
10. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007 39 : 44 84.
11. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003 361 : 2017 23.
12. Honarbakhsh S, Schachter M. Vitamins and cardiovascular disease. Br J Nutr 2008 October 1, Epub ahead of print.
13. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008 300 : 2123 33.
14. Tepel M, van der Giet M, Statz M, Jankowski J, Zidek W. The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation 2003 107 : 992 5.
15. Friedman AN, Bostom AG, Laliberty P, Selhub J, Shemin D. The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: a randomized, controlled study. Am J Kidney Dis 2003 41 : 442 6.
16. Andrews NP, Prasad A, Quyyumi AA. N-acetylcysteine improves coronary and peripheral vascular function. J Am Coll Cardiol 2001 37 : 117 23.
17. Ueda S, Yasunari K. What we learnt from randomized clinical trials and cohort studies of antioxidant vitamin? Focus on vitamin E and cardiovascular disease. Curr Pharm Biotechnol 2006 7 : 69 72.
18. Antoniades C, Tousoulis D, Tentolouris C, Toutouzas P, Stefanadis C. Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice. Herz 2003 28 : 628 38.
19. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med 1995 123 : 860 72.
20. Lawlor DA, Davey Smith G, Kundu D, Bruckdorfer KR, Ebrahim S. Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet 2004 363 : 1724 7.
21. Voss P, Siems W. Clinical oxidation parameters of aging. Free Radic Res 2006 40 : 1339 49.
22. Veglia F, Cighetti G, De Franceschi M, Zingaro L, Boccotti L, Tremoli E et al. Age- and gender-related oxidative status determined in healthy subjects by means of OXY-SCORE, a potential new comprehensive index. Biomarkers 2006 11 : 562 73.
23. Hernanz A, Fernandez-Vivancos E, Montiel C, Vazquez JJ, Arnalich F. Changes in the intracellular homocysteine and glutathione content associated with aging. Life Sci 2000 67 : 1317 24.
24. Hernanz A, Fernandez-Vivancos E, Salazar RM, Arnalich F. Homocysteine and other thiol compounds in ageing. Biofactors 2000 11 : 47 9.
25. Lenton KJ, Therriault H, Cantin AM, Fulop T, Payette H, Wagner JR. Direct correlation of glutathione and ascorbate and their dependence on age and season in human lymphocytes. Am J Clin Nutr 2000 71 : 1194 200.
26. Yang CS, Chou ST, Liu L, Tsai PJ, Kuo JS. Effect of ageing on human plasma glutathione concentrations as determined by high-performance liquid chromatography with fluorimetric detection. J Chromatogr B Biomed Appl 1995 674 : 23 30.
27. Ortona E, Margutti P, Matarrese P, Franconi F, Malorni W. Redox state, cell death and autoimmune diseases: a gender perspective. Autoimmun Rev 2008 7 : 579 84.
28. Violi F, Cangemi R. Antioxidants and cardiovascular disease. Curr Opin Investig Drugs 2005 6 : 895 900.
29. Werba JP, Cavalca V, Veglia F, Massironi P, De Franceschi M, Zingaro L et al. A new compound-specific pleiotropic effect of statins: modification of plasma gamma-tocopherol levels. Atherosclerosis 2007 193 : 229 33.
30. Cighetti G, Debiasi S, Paroni R, Allevi P. Free and total malondialdehyde assessment in biological matrices by gas chromatography-mass spectrometry: what is needed for an accurate detection. Anal Biochem 1999 266 : 222 9.
31. Tosukhowong P, Sangwatanaroj S, Jatuporn S, Prapunwattana P, Saengsiri A, Rattanapruks S et al. The correlation between markers of oxidative stress and risk factors of coronary artery disease in Thai patients. Clin Hemorheol Microcirc 2003 29 : 321 9.
32. Tsuru R, Hojo Y, Gama M, Mizuno O, Katsuki T, Shimada K. Redox imbalance in patients with coronary artery disease showing progression of atherosclerotic lesions. J Cardiol 2006 48 : 183 91.
33. Bridges AB, Scott NA, Pringle TH, McNeill GP, Belch JJ. Relationship between the extent of coronary artery disease and indicators of free radical activity. Clin Cardiol 1992 15 : 169 74.
34. Miwa K, Miyagi Y, Igawa A, Nakagawa K, Inoue H. Vitamin E deficiency in variant angina. Circulation 1996 94 : 14 8.
35. Serdar Z, Aslan K, Dirican M, Sarandol E, Yesilbursa D, Serdar A. Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. Clin Biochem 2006 39 : 794 803.
36. Haidari M, Javadi E, Kadkhodaee M, Sanati A. Enhanced susceptibility to oxidation and diminished vitamin E content of LDL from patients with stable coronary artery disease. Clin Chem 2001 47 : 1234 40.
37. Nojiri S, Daida H, Mokuno H, Iwama Y, Mae K, Ushio F et al. Association of serum antioxidant capacity with coronary artery disease in middle-aged men. Jpn Heart J 2001 42 : 677 90.
38. Ruiz Rejon F, Martin-Pena G, Granado F, Ruiz-Galiana J, Blanco I, Olmedilla B. Plasma status of retinol, alpha- and gamma-tocopherols, and main carotenoids to first myocardial infarction: case control and follow-up study. Nutrition 2002 18 : 26 31.
39. Morton LW, Ward NC, Croft KD, Puddey IB. Evidence for the nitration of gamma-tocopherol in vivo: 5-nitro-gamma-tocopherol is elevated in the plasma of subjects with coronary heart disease. Biochem J 2002 364 : 625 8.
40. Kontush A, Spranger T, Reich A, Baum K, Beisiegel U. Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of alpha-carotene and gamma-tocopherol. Atherosclerosis 1999 144 : 117 22.